Prevalence, Clinical Characteristics and Treatment of Bulgarian Patients With Resistant Hypertension

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Study objectives: Our study aimed to assess the prevalence, characteristics, and treatment of patients with resistant hypertension (HTN) in Bulgarian hypertensive population. Methods: We screened 4340 consecutive cardiovascular patients hospitalized in our clinic and identified 3762 with HTN. Of them, 128 fulfilled the current (2018) European Society of Cardiology and (2023) European Society of Hypertension criteria for resistant HTN and were included in our study. We matched these patients to 128 hospitalized patients with controlled HTN.
Trial Details
NCT Number NCT07877844
Lead Sponsor Medical University of Sofia
Conditions
(from sponsor)		 Resistant Hypertension, Controlled Hypertension
Related terms Hypertension
Enrollment 256 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov